1. HIV-1 induces cardiomyopathy by cardiomyocyte invasion and gp120, tat, and cytokine apoptotic signaling

   • Milan Fiala
   • Waldemar Polik
   • James Arthos

   Original Contributions Pages: 97 - 107

2. Pro-oxidant properties and cytotoxicity of AZT-Monophosphate and AZT

   • I. Tong Mak
   • Lucie F. Nedelec
   • William B. Weglicki

   Original Contributions Pages: 109 - 115

3. Effects of HIV drug combinations on endothelin-1 and vascular cell proliferation

   • Valeria Y. Hebert
   • Brian L. Crenshaw
   • Tammy R. Dugas

   Original Contributions Pages: 117 - 131

4. Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3′-azido-3′-deoxythymidine

   • Dale M. Walker
   • Miriam C. Poirier
   • Vernon E. Walker

   Original Contributions Pages: 133 - 153

5. Phosphorylation of thymidine and AZT in heart mitochondria

   • Edward E. McKee
   • Alice T. Bentley
   • Delia Susan-Resiga

   Original Contributions Pages: 155 - 167

6. Cardiac pathologic effects of azidothymidine (AZT) in Mg-deficient mice

   • I. Tong Mak
   • Maya G. Goldfarb
   • Christian C. Haudenschild

   Original Contributions Pages: 169 - 177

7. Changes in thrombolytic and inflammatory markers after initiation of indinavir- or amprenavir-based antiretroviral therapy

   • Erika M. Young
   • Robert V. Considine
   • Michael P. Dubé

   Original Contributions Pages: 179 - 186

8. Cardiovascular outcomes of pediatric seroreverters perinatally exposed to HAART

   • Jill E. Lavigne
   • William T. Shearer
   • CHAART Study Group

   Original Contributions Pages: 187 - 197

9. Vascular endothelial toxicity induced by HIV protease inhibitor

   • Reshma S. Baliga
   • Cynthia Liu
   • John A. Bauer

   Original Contributions Pages: 199 - 206